The Effects of Treating Male Hypogonadism on Couples' Sexual Desire and Function

被引:17
作者
Conaglen, John V. [2 ]
Conaglen, Helen M. [1 ]
机构
[1] Univ Waikato, Dept Psychol, Hamilton, New Zealand
[2] Univ Auckland, Waikato Clin Sch, Fac Med & Hlth Sci, Auckland 1, New Zealand
关键词
Hypogonadism; Testosterone Replacement Therapy; Sexual Desire; Sexual Function; Couples; TESTOSTERONE REPLACEMENT THERAPY; NORMALIZES ANDROGEN LEVELS; ERECTILE FUNCTION IIEF; INTERNATIONAL INDEX; BODY-COMPOSITION; MEN; DYSFUNCTION; HYPERPROLACTINEMIA; CABERGOLINE; IMPROVEMENTS;
D O I
10.1111/j.1743-6109.2008.01043.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypogonadism is a common endocrine condition characterized by low levels of testosterone (T) and marked by numerous symptoms, one of which is low sexual desire. Studies comparing T delivery systems have suggested that hypogonadal men's partners may be at risk from exposure to T gels. Little other mention is found of the impact of hypogonadism and its treatment on a man's partner and the couple's sexual function. To assess sexual desire and sexual function in hypogonadal men and their woman partners before and after treatment with T replacement therapy. Twenty-one hypogonadal men and 18 partners were recruited from a tertiary endocrine clinic, and were compared with a control group of 20 eugonadal age-matched men and their partners. All men had baseline blood tests to confirm their status as hypogonadal or eugonadal, and hypogonadal men repeated tests at 3-month intervals. All participants completed the Sexual Desire Inventory (SDI) and sexual function questionnaires at baseline and at 3-month intervals until the hypogonadal men attained normal T levels. Pre- and post-treatment SDI and sexual function questionnaires were compared once T normalization was achieved. Between- and within-group comparisons were carried out. Pretreatment hypogonadal men recorded lower levels of sexual desire and function than controls, but significantly improved once hypogonadism was corrected. Eugonadal controls recorded no significant changes in either sexual desire or function during the study. Partners of the hypogonadal men reported no changes on the SDI, but significant improvements in sexual function as their partners recovered. SDI and sexual function measures reflect sexual changes that accompany rising serum T levels during correction of male hypogonadism. Women partners reported more satisfaction, less pain, and improved sexual function following the men's treatment. Treatments affecting one partner potentially have important effects on the other. Conaglen JV, and Conaglen HM. The effects of treating male hypogonadism on couples' sexual desire and function. J Sex Med 2009;6:456-463.
引用
收藏
页码:456 / 463
页数:8
相关论文
共 34 条
[1]   Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men [J].
Arver, S ;
Dobs, AS ;
Meikle, AW ;
Caramelli, KE ;
Rajaram, L ;
Sanders, SW ;
Mazer, NA .
CLINICAL ENDOCRINOLOGY, 1997, 47 (06) :727-737
[2]   HYPOACTIVE SEXUAL DESIRE DISORDER - AN OVERVIEW [J].
BECK, JG .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1995, 63 (06) :919-927
[3]   Hyperprolactinemia and sexual function in men: a short review [J].
Buvat, J .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (05) :373-377
[4]  
CONAGLEN HM, 1999, THESIS U WAIKATO HAM
[5]   Effect of hyperprolactinemia in male patients consulting for sexual dysfunction [J].
Corona, Giovanni ;
Mannucci, Ecloardo ;
Fisher, Alessandra D. ;
Lotti, Francesco ;
Ricca, Valdo ;
Balercia, Giancarlo ;
Petrone, Luisa ;
Forti, Gianni ;
Maggi, Mario .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (05) :1485-1493
[6]   Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction [J].
Corona, Giovanni ;
Mannucci, Edoardo ;
Schulman, Claude ;
Petrone, Luisa ;
Mansani, Riccardo ;
Cilotti, Antonio ;
Balercia, Giancarlo ;
Chiarini, Valerio ;
Forti, Gianni ;
Maggi, Mario .
EUROPEAN UROLOGY, 2006, 50 (03) :595-604
[7]  
Darby Emily, 2005, Treat Endocrinol, V4, P293, DOI 10.2165/00024677-200504050-00003
[8]   A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients [J].
de Luis, DA ;
Becerra, A ;
Lahera, M ;
Botella, JI ;
Valero, MA ;
Varela, C .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (07) :428-434
[9]  
Dean John D, 2004, Rev Urol, V6 Suppl 6, pS22
[10]  
DONAHEY KM, 1993, J SEX MARITAL THER, V19, P25